Abstract
When used alone, both vanadate and hydrogen peroxide (H2O2) are weakly insulin-mimetic, while in combination they are strongly synergistic due to the formation of aqueous peroxovanadium species pV(aq). Administration of these pV(aq) species leads to activation of the insulin receptor tyrosine kinase (IRK), autophosphorylation at tyrosine residues and inhibition of phosphotyrosine phosphatases (PTPs). We therefore undertook to synthesize a series of peroxovanadium (pV) compounds containing one or two peroxo anions, an oxo anion and an ancillary ligand in the inner co-ordination sphere of vanadium, whose properties and insulin-mimetic potencies could be assessed. These pV compounds were shown to be the most potent inhibitors of PTPs yet described. Their PTP inhibitory potency correlated with their capacity to stimulate IRK activity. Some pV compounds showed much greater potency as inhibitors of insulin receptor (IR) dephosphorylation than epidermal growth factor receptor (EGFR) dephosphorylation, implying relative specificity as PTP inhibitors. Replacement of vanadium with either molybdenum or tungsten resulted in equally potent inhibition of IR dephosphorylation. However IRK activation was reduced by greater than 80% suggesting that these compounds did not access intracellular PTPs. The insulin-like activity of these pV compounds were demonstrable in vivo. Intra venous (i.v.) administration of bpV(pic) and bpV(phen) resulted in the lowering of plasma glucose concentrations in normal rats in a dose dependent manner. The greater potency of bpV(pic) compared to bpV(phen) was explicable, in part, by the capacity of the former but not the latter to act on skeletal muscle as well as liver. Finally administration of bpV(phen) and insulin led to a synergism, where tyrosine phosphorylation of the IR β-subunit increased by 20-fold and led to the appearance of four insulin-dependent in vivo substrates. The insulin-mimetic properties of the pV compounds raises the possibility for their use as insulin replacements in the management of diabetes mellitus.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Tolman EL, Barris E, Bums M, Pansini A, Partridge R: Effects of vanadium on glucose metabolism in vitro. Life Sci 25: 1159–1164, 1979
Dubyak GR, Kleinzeller A: The insulin-mimetic effects of vanadate in isolated rat adipocytes. Dissociation from effects of vanadate as a (Na+-K+)ATPase inhibitor. J Biol Chem 255: 5306–5312, 1980
Shechter Y, Karlish S J: Insulin-like stimulation of glucose oxidation in rat adipocytes by vanadyl (IV) ions. Nature 284: 556–558, 1980
Tamura S, Brown TA, Whipple JH, Fujita-Yamaguchi Y, Dubler RE, Cheng K, Larner J: A novel mechanism for the insulin-like effect of vanadate on glycogen synthase in rat adipocytes. J Biol Chem 259: 6650–6658, 1984
Clark AS, Fagan JM, Mitch WE: Selectivity of the insulin-like actions of vanadate on glucose and protein metabolism in skeletal muscle. Biochem J 232: 273–276, 1985
Kadota S, Fantus IG, Hersh B, Posner Bl: Vanadate stimulation of IGF binding to rat adipocytes. Biochem Biophys Res Commun 138: 174–178, 1986
Kadota S, Fantus IG, Deragon G, Guyda HJ, Posner Bl: Stimulation of insulin-like growth factor 11 receptor binding and insulin receptor kinase activity in rat adipocytes. Effects of vanadate and H2O2. J Biol Chem 262: 8252–8256, 1987
Strout HV, Vicario PP, Saperstein R, Slater EE: The insulin-mimetic effect of vanadate is not correlated with insulin receptor tyrosine kinase activity nor phosphorylation in mouse diaphragm in vivo. Endocrinology 124: 1918–1924, 1989
Heyliger CE, Tahiliani AG, McNeill JH: Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Science 227: 1474–1477, 1985
Meyerovitch J, Farfel Z, Sack J, Shechter Y: Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats. Characterization and mode of action. J Biol Chem 262: 6658–6662, 1987
Brichard SM, Okitolonda W, Henquin JC: Long term improvement of glucose homeostasis by vanadate treatment in diabetic rats. Endocrinology 123: 2048–2053, 1988
Blondel O, Bailbe D, Portha B: In vivo insulin resistance in streptozotocin-diabetic rats-evidence for reversal following oral vanadate treatment. Diabetologia 32: 185–190, 1989
Gil J, Miralpeix M, Carreras J, Bartrons R: Insulin-like effects of vanadate on glucokinase activity and fructose 2,6-bisphosphate levels in the liver of diabetic rats. J Biol Chem 263: 1868–1871, 1988
Czech MP, Lawrence JCJ, Lynn WS: Evidence for the involvement of sulfhydryl oxidation in the regulation of fat cell hexose transport by insulin. Proc Natl Acad Sci USA 71:4173–4177, 1974
May JM, de Haen C: The insulin-like effect of hydrogen peroxide on pathways of lipid synthesis in rat adipocytes. J Biol Chem 254: 9017–9021, 1979
Lawrence JCJ, Larner J: Activation of glycogen synthase in rat adipocytes by insulin and glucose involves increased glucose transport and phosphorylation. J Biol Chem 253: 2104–2113, 1978
Little SA, de Haen C: Effects of hydrogen peroxide on basal and hormone-stimulated lipolysis in perifused rat fat cells in relation to the mechanism of action of insulin. J Biol Chem 255: 10888–10895, 1980
Heflfetz D, Zick Y: H2O2 potentiates phosphorylation of novel putative substrates for the insulin receptor kinase in intact Fao cells. J Biol Chem 264: 10126–10132, 1989
Kadota S, Fantus IG, Deragon G, Guyda HJ, Hersh B, Posner Bl: Peroxide(s) of vanadium: a novel and potent insulin-mimetic agent which activates the insulin receptor kinase. Biochem Biophys Res Commun 147: 259–266, 1987
Heffetz D, Bushkin I, Dror R, Zick Y: The insulinomimetic agents H2O2 and vanadate stimulate protein tyrosine phosphorylation in intact cells. J Biol Chem 265: 2896–2902, 1990
Fantus IG, Kadota S, Deragon G, Foster B, Posner Bl: Pervanadate [peroxide(s) of vanadate] mimics insulin action in rat adipocytes via activation of the insulin receptor tyrosine kinase. Biochemistry 28: 8864–8871, 1989
Shisheva A, Shechter Y: Mechanism of pervanadate stimulation and potentiation of insulin-activated glucose transport in rat adipocytes: dissociation from vanadate effect. Endocrinology 133: 1562–1568, 1993
Hadari YR, Geiger B, Nadiv O, Sabanay I, Roberts CTJ, LeRoith D, Zick Y: Hepatic tyrosine-phosphorylated proteins identified and localized following in vivo inhibition of protein tyrosine phosphatases: effects of H2O2 and vanadate administration into rat livers. Mol Cell Endocrinol 97: 9–17, 1993
Posner Bl, Faure R, Burgess JW, Bevan AP, Lachance D, Zhang-Sun G, Fantus IG, Ng JB, Hall DA, Lum BS, Shaver A: Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics. J Biol Chem 269: 4596–4604, 1994
Jakubowski J, Jakob A: Vasopressin, insulin and peroxide(s) of vanadate (pervanadate) influence Na+ transport mediated by (Na+, K+)ATPase or Na+/H+ exchanger of rat liver plasma membrane vesicles. Eur J Biochem 193: 541–549, 1990
Imbert V, Peyron JF, Farahi Far D, Mari B, Auberger P, Rossi B: Induction of tyrosine phosphorylation and T-cell activation by vanadate peroxide, an inhibitor of protein tyrosine phosphatases. Biochem J 297: 163–173, 1994
Harrison ML, Isaacson CC, Burg DL, Geahlen RL, Low PS: Phosphorylation of human erythrocyte band 3 by endogenous p72syk. J Biol Chem 269: 955–959, 1994
Khan MN, Baquiran G, Brule C, Burgess J, Foster B, Bergeron JJ, Posner Bl: Internalization and activation of the rat liver insulin receptor kinase in vivo. J Biol Chem 264: 12931–12940, 1989
Burgess JW, Wada I, Ling N, Khan MN, Bergeron JJ, Posner Bl: Decrease in beta-subunit phosphotyrosine correlates with internalization and activation of the endosomal insulin receptor kinase. J Biol Chem 267: 10077–10086, 1992
Faure R, Baquiran G, Bergeron JJ, Posner Bl: The dephosphorylation of insulin and epidermal growth factor receptors. Role of endosome-associated phosphotyrosine phosphatase(s). J Biol Chem 267: 11215–11221, 1992
Guan KL, Dixon JE: Protein tyrosine phosphatase activity of an essential virulence determinant in Yersinia. Science 249: 553–556, 1990
Guan KL, Haun RS, Watson SJ, Geahlen RL, Dixon JE: Cloning and expression of a protein-tyrosine-phosphatase. Proc Natl Acad Sci USA 87: 1501–1505, 1990
Guan KL, Dixon JE: Evidence for protein-tyrosine-phosphatase catalysis proceeding via a cysteine-phosphate intermediate. J Biol Chem 266: 17026–17030, 1991
Pot DA, Dixon JE: Active site labeling of a receptor-like protein tyrosine phosphatase. J Biol Chem 267: 140–143, 1992
Shaver A, Ng JB, Hall DA, Lum BS, Posner Bl: Insulin mimetic peroxovanadium complexes: preparation and structure of potassium oxodiperoxo (pyridine-2-carboxylato) vanadate(V), K2[VO(O2)2(C5H4NCOO)]·2H2O, and potassium oxodiperoxo(3-hydro-ypyridine-2-carboxylato)vanadate(V), K2[VO(O2)2(OHC5H3NCOO)].3H2O, and their reactions with cysteine. Inorg Chem 32: 3109–3113, 1993
Tracey AS, Gresser MJ: Interaction of vanadate with phenol and tyrosine: implications for the effects of vanadate on systems regulated by tyrosine phosphorylation. Proc Natl Acad Sci USA 83: 609–613, 1986
Barford D, Flint AJ, Tonks NK: Crystal structure of human protein tyrosine phosphatase 1 B. Science 263: 1397–1404, 1994
Bevan AP, Burgess JW, Yale J-F, Drake PG, Lachance D, Baquiran G, Shaver A, Posner Bl: In vivo insulin-mimetic effects of peroxovanadium compounds: A role for tissue targeting in determining potency. Am J Physiol 268: E60–E66, 1995
Shisheva A, Ikonomov O, Shechter Y: The protein tyrosine phosphatase inhibitor, pervanadate, is a powerful antidiabetic agent in streptozotocin-treated diabetic rats. Endocrinology 134: 507–510, 1994
Lonnroth P, Eriksson JW, Posner Bl, Smith U: Peroxovanadate but not vanadate exerts insulin-like effects in human adipocytes. Diabetologia 36: 113–116, 1993
Foot E, Bliss T, Fernandes LC, DaCosta C, Leighton B: The effects of orthovanadate, vanadyl and peroxides of vanadate on glucose metabolism in skeletal muscle preparations in vitro. Mol Cell Biochem 109: 157–162, 1992
Leighton B, Cooper GJS, DaCosta C, Foot EA: Peroxovanadates have full insulin-like effects on glycogen synthesis in normal and insulin-resistant skeletal muscle. Biochem J 276: 289–292, 1991
Hadari YR, Tzahar E, Nadiv O, Rothenberg P, Roberts CTJ, LeRoith D, Yarden Y, Zick Y: Insulin and insulinomimetic agents induce activation of phosphatidylinositol 3′-kinase upon its association with pp185 (IRS-1) in intact rat livers. J Biol Chem 267: 17483–17486, 1992
Zick Y, Sagi-Eisenberg R: A combination of H2O2 and vanadate concomitantly stimulates protein tyrosine phosphorylation and polyphosphoinositide breakdown in different cell lines. Biochemistry 29: 10240–10245, 1990
Heffetz D, Rutter WJ, Zick Y: The insulinomimetic agents H2O2 and vanadate stimulate tyrosine phosphorylation of potential target proteins for the insulin receptor kinase in intact cells. Biochem J 288: 631–635, 1992
Bourgoin S, Grinstein S: Peroxides of vanadate induce activation of phospholipase D in HL-60 cells. Role of tyrosine phosphorylation. J Biol Chem 267: 11908–11916, 1992
O’Shea JJ, McVicar DW, Bailey TL, Burns C, Smyth MJ: Activation of human peripheral blood T lymphocytes by pharmacological induction of protein-tyrosine phosphorylation. Proc Natl Acad Sci USA 89: 10306–10310, 1992
Estrada DE, Elliott E, Zinman B, Poon I, Liu Z, Klip A, Daneman D: Regulation of glucose transport and expression of GLUT3 transporters in human circulating mononuclear cells: studies in cells from insulin-dependent diabetic and nondiabetic individuals. Metabolism 43: 591–598, 1994
Modderman PW, von dem Borne AE, Sonnenberg A: Tyrosine phosphorylation of P-selectin in intact platelets and in a disulphide-linked complex with immunoprecipitated pp60c-src. Biochem J 299: 613–621, 1994
Inazu T, Taniguchi T, Yanagi S, Yamamura H: Protein-tyrosine phosphorylation and aggregation of intact human platelets by vanadate with H2O2. Biochem Biophys Res Commun 170: 259–263, 1990
Rafaelsen OJ, Lauris V, Renold AE: Localized intraperitoneal action of insulin on rat diaphragm and epididymal adipose tissue in vivo. Diabetes 14:19–26, 1965
Burgess JW, Bevan AP, Bergeron JJM, Posner Bl: Pharmacological doses of insulin equalize insulin phosphotyrosine content but not tyrosine kinase activity in plasmalemmal and endosomal membranes. Biochem Cell Biol 70: 1151–1158, 1992
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Kluwer Academic Publishers
About this chapter
Cite this chapter
Bevan, A.P., Drake, P.G., Yale, JF., Shaver, A., Posner, B.I. (1995). Peroxovanadium compounds: Biological actions and mechanism of insulin-mimesis. In: Srivastava, A.K., Chiasson, JL. (eds) Vanadium Compounds: Biochemical and Therapeutic Applications. Developments in Molecular and Cellular Biochemistry, vol 16. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1251-2_6
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1251-2_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8533-5
Online ISBN: 978-1-4613-1251-2
eBook Packages: Springer Book Archive